<GlossaryTerm id="CDR0000795665"><TermName>anaplastic lymphoma kinase inhibitor</TermName><TermPronunciation>(A-nuh-PLAS-tik lim-FOH-muh KY-nays in-HIH-bih-ter)</TermPronunciation><TermDefinition><DefinitionText>A substance that blocks the activity of a protein called anaplastic lymphoma kinase (ALK), which helps control cell growth. Blocking this protein may help keep cancer cells from growing and spreading. Some  anaplastic lymphoma kinase inhibitors are used to treat cancer. They are a type of targeted therapy. Also called ALK inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000797264" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anaplastic lymphoma kinase inhibitor&quot;" language="en" id="_3"/><MediaLink ref="CDR0000797263" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la cinasa del linfoma anaplásico&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de la cinasa del linfoma anaplásico</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que impide la actividad de una proteína que se llama cinasa del linfoma anaplásico (ALK), que ayuda a controlar el crecimiento de las células. Es posible que el bloqueo de esta proteína ayude a impedir que se formen y se diseminen las células cancerosas. Algunos inhibidores de la cinasa del linfoma anaplásico se usan para tratar el cáncer. Son un tipo de sustancias que se utilizan para la terapia dirigida También se llama inhibidor de ALK e inhibidor de la quinasa del linfoma anaplásico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2019-01-03</DateFirstPublished></GlossaryTerm>
